Langxia Liu

1.4k total citations
40 papers, 1.1k citations indexed

About

Langxia Liu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Langxia Liu has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Langxia Liu's work include RNA modifications and cancer (10 papers), RNA Research and Splicing (8 papers) and Ubiquitin and proteasome pathways (6 papers). Langxia Liu is often cited by papers focused on RNA modifications and cancer (10 papers), RNA Research and Splicing (8 papers) and Ubiquitin and proteasome pathways (6 papers). Langxia Liu collaborates with scholars based in China, Australia and France. Langxia Liu's co-authors include Clarisse Berlioz‐Torrent, Serge Bénichou, Sylvie Le Gall, Jean‐Michel Heard, Richard Bénarous, Lars Erdtmann, Olivier Schwartz, Xuejuan Gao, Qing‐Yu He and Xuezhang Xiao and has published in prestigious journals such as Immunity, Journal of Molecular Biology and Scientific Reports.

In The Last Decade

Langxia Liu

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Langxia Liu China 18 523 306 225 217 182 40 1.1k
Manqing Li China 12 581 1.1× 278 0.9× 194 0.9× 39 0.2× 56 0.3× 26 1.1k
Florence Verrier France 13 348 0.7× 145 0.5× 165 0.7× 54 0.2× 35 0.2× 14 666
Yi-Ting Cheng United States 16 590 1.1× 61 0.2× 77 0.3× 36 0.2× 37 0.2× 29 1.1k
Michel Baron France 17 623 1.2× 331 1.1× 14 0.1× 47 0.2× 57 0.3× 31 1.2k
Shaojun Xing China 20 461 0.9× 1.1k 3.7× 111 0.5× 120 0.6× 97 0.5× 40 1.8k
Julie Mazzolini France 13 186 0.4× 270 0.9× 147 0.7× 49 0.2× 31 0.2× 20 600
Annemarie Shibata United States 18 513 1.0× 119 0.4× 212 0.9× 47 0.2× 236 1.3× 31 1.2k
Richard H. Tullis United States 13 947 1.8× 174 0.6× 28 0.1× 33 0.2× 418 2.3× 22 1.3k
Elias Quijano United States 17 1.0k 1.9× 67 0.2× 37 0.2× 38 0.2× 153 0.8× 28 1.4k

Countries citing papers authored by Langxia Liu

Since Specialization
Citations

This map shows the geographic impact of Langxia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Langxia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Langxia Liu more than expected).

Fields of papers citing papers by Langxia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Langxia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Langxia Liu. The network helps show where Langxia Liu may publish in the future.

Co-authorship network of co-authors of Langxia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Langxia Liu. A scholar is included among the top collaborators of Langxia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Langxia Liu. Langxia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jing, et al.. (2025). Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2. Cell Death and Disease. 16(1). 513–513. 3 indexed citations
2.
Gao, Xuejuan, Ying Liu, Xiaofen Zheng, et al.. (2025). FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma. Cell Death and Disease. 16(1). 63–63. 3 indexed citations
3.
Liu, Langxia, et al.. (2024). TRIAL-based combination therapies in cancers. International Immunopharmacology. 138. 112570–112570. 6 indexed citations
4.
5.
Liu, Langxia, et al.. (2023). E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis. 2(2). 37–48. 3 indexed citations
6.
Meng, Meng, Meizhi Lu, Junxia Feng, et al.. (2023). Exosomal PPARγ derived from macrophages suppresses LPS-induced peritonitis by negative regulation of CD14/TLR4 axis. Inflammation Research. 72(8). 1567–1581. 2 indexed citations
7.
Wang, Yang, Yanyan Chen, Nan‐Nan Yu, et al.. (2023). Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase. Molecular Therapy. 31(7). 2169–2187. 20 indexed citations
8.
Zheng, Xiaofen, et al.. (2023). GSK3β/ITCH/c-FLIP Axis Counteracts TRAIL-induced Apoptosis inHuman Lung Adenocarcinoma Cells. Protein and Peptide Letters. 30(3). 242–249. 3 indexed citations
9.
Li, Lu, Shiyuan Wen, Xuejuan Gao, et al.. (2022). DDX17 promotes the growth and metastasis of lung adenocarcinoma. Cell Death Discovery. 8(1). 425–425. 12 indexed citations
10.
Liu, Xiaohui, et al.. (2021). ANXA1–GSK3β interaction and its involvement in NSCLC metastasis. Acta Biochimica et Biophysica Sinica. 53(7). 912–924. 7 indexed citations
11.
Wang, Ziyi, Heng Qiu, Jianbo He, et al.. (2019). The emerging roles of hnRNPK. Journal of Cellular Physiology. 235(3). 1995–2008. 105 indexed citations
12.
Zhang, Tingting, Wensi Huang, Xiaohui Liu, et al.. (2019). YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth. Acta Biochimica et Biophysica Sinica. 51(7). 677–687. 7 indexed citations
13.
Wang, Cuihua, Shengyou Liao, Wei Gu, et al.. (2017). The flightless I protein interacts with RNA-binding proteins and is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells. International Journal of Oncology. 51(1). 347–361. 5 indexed citations
14.
Gao, Xuejuan, Junxia Feng, Yujiao He, et al.. (2016). hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells. Scientific Reports. 6(1). 22999–22999. 27 indexed citations
15.
Fan, Xiaoqin, et al.. (2015). A homogeneous time-resolved fluorescence-based high-throughput screening for discovery of inhibitors of Nef-sdAb19 interaction. International Journal of Oncology. 47(4). 1485–1493. 1 indexed citations
16.
Fan, Xiaoqin, Xuejuan Gao, Xiaohui Liu, et al.. (2015). Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation. Scientific Reports. 5(1). 17732–17732. 39 indexed citations
17.
Li, Nan, Xiao-Yan Yang, Zhong Guo, et al.. (2014). Varied metal-binding properties of lipoprotein PsaA in Streptococcus pneumoniae. JBIC Journal of Biological Inorganic Chemistry. 19(6). 829–838. 19 indexed citations
18.
Liu, Tengfei, Xuejuan Gao, Xiaohui Liu, et al.. (2014). Direct Interaction of 14-3-3ζ with Ezrin Promotes Cell Migration by Regulating the Formation of Membrane Ruffle. Journal of Molecular Biology. 426(18). 3118–3133. 14 indexed citations
19.
Yan, Guang‐Rong, et al.. (2011). Global identification of miR‐373‐regulated genes in breast cancer by quantitative proteomics. PROTEOMICS. 11(5). 912–920. 71 indexed citations
20.
Gall, Sylvie Le, Lars Erdtmann, Serge Bénichou, et al.. (1998). Nef Interacts with the μ Subunit of Clathrin Adaptor Complexes and Reveals a Cryptic Sorting Signal in MHC I Molecules. Immunity. 8(4). 483–495. 322 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manqing Li Breakdown of academic impact, for papers by Florence Verrier Breakdown of academic impact, for papers by Yi-Ting Cheng Breakdown of academic impact, for papers by Michel Baron Breakdown of academic impact, for papers by Shaojun Xing Breakdown of academic impact, for papers by Julie Mazzolini Breakdown of academic impact, for papers by Annemarie Shibata Breakdown of academic impact, for papers by Richard H. Tullis Breakdown of academic impact, for papers by Elias Quijano
Rankless by CCL
2026